Management

Jimmy Vanhove brings extensive experience in strategy, operational management, and digital transformation in the biotech/pharma industry. He has held various leadership positions with increased responsibility in manufacturing and strategy consulting at multinational companies like GSK Vaccines, Bayer, and Roland Berger. Before j...

Jimmy Vanhove brings extensive experience in strategy, operational management, and digital transformation in the biotech/pharma industry. He has held various leadership positions with increased responsibility in manufacturing and strategy consulting at multinational companies like GSK Vaccines, Bayer, and Roland Berger. Before joining Viralgen in 2021, he worked as the chief of staff for Bayer Pharma Product Supply. Jimmy holds a master’s degree in Bioscience Engineering from KU Leuven, and in General Management from Vlerick Business School. He has also received executive training in Digital Transformation at IMD, Lausanne, and Executive Management Development at IESE business school, Barcelona.

Almost 30 years of experience working in healthcare and the biopharmaceutical industry. Since 2009, Mr. García has focused on life science venture capital investing, where he focuses on private company investments in the biopharmaceutical, life science and medical technology sectors. Mr. García received a bachelor's in mathemati...

Almost 30 years of experience working in healthcare and the biopharmaceutical industry. Since 2009, Mr. García has focused on life science venture capital investing, where he focuses on private company investments in the biopharmaceutical, life science and medical technology sectors. Mr. García received a bachelor's in mathematics (Statistics and Operations Research) from Universidad Complutense of Madrid and an MBA from ICADE (Spain). He's also president and founder of Columbus Venture Partner, and co-founder of Columbus Children's Foundation.

Doctor in Molecular Biology. Over 20 years of leadership experience in the biotechnology field with special interest in gene therapy and immunology in both industry and academic settings.

Doctor in Molecular Biology. Over 20 years of leadership experience in the biotechnology field with special interest in gene therapy and immunology in both industry and academic settings.

Patrick Barry is Vice President of Business Development at Viralgen since March 2022. Patrick has more than 20 years of experience in the Viral and Gene Therapy (VGT) industry for both testing, production and process development. Prior to joining Viralgen Patrick spent over 20 years with Millipore Sigma/BioReliance in increasing...

Patrick Barry is Vice President of Business Development at Viralgen since March 2022. Patrick has more than 20 years of experience in the Viral and Gene Therapy (VGT) industry for both testing, production and process development. Prior to joining Viralgen Patrick spent over 20 years with Millipore Sigma/BioReliance in increasing commercial roles. These roles included numerous regulatory and testing programs from preclinical through commercial programs for both VGT and biologics molecules. Patrick has a M.Sc. from the University of Massachusetts and an MBA from Babson Coll.

Highly experienced lawyer specialized in People Management. Over the past 25 years, she has worked on Team and Management Development, gaining expertise in a variety of international companies dedicated to various fields including the financial, industrial, health, distribution and aeronautics industries. She also has a strong a...

Highly experienced lawyer specialized in People Management. Over the past 25 years, she has worked on Team and Management Development, gaining expertise in a variety of international companies dedicated to various fields including the financial, industrial, health, distribution and aeronautics industries. She also has a strong academic foundation: a degree in law and a master’s degree in human resources. After searching for a company committed to human development where challenges are available, Kontxi comes to Viralgen as Chief Human Resources to contribute to the business growth.

With a degree in Business Administration and Management from the Public University of Navarra, over 15 years Marta has worked and gained expertise in the field of financial auditing, strategic consulting and financial control. She comes to Viralgen with the aim of ensuring the correct use of the company's financial resources and...

With a degree in Business Administration and Management from the Public University of Navarra, over 15 years Marta has worked and gained expertise in the field of financial auditing, strategic consulting and financial control. She comes to Viralgen with the aim of ensuring the correct use of the company's financial resources and for its well-being and economic stability.

Joined Viralgen in May 2017 after working as collaborator of Bamboo Therapeutics from March 2015 through July 2016. Philippe Moullier was the founder and, until Dec 2016, the Director of the research INSERM Unit UMR 1089 entitled « Translational Gene Therapy for Retinal and Neuromuscular Diseases » at the University of Nantes, F...

Joined Viralgen in May 2017 after working as collaborator of Bamboo Therapeutics from March 2015 through July 2016. Philippe Moullier was the founder and, until Dec 2016, the Director of the research INSERM Unit UMR 1089 entitled « Translational Gene Therapy for Retinal and Neuromuscular Diseases » at the University of Nantes, France. In January 2018, Philippe Moullier was appointed as Chief Development Officer at Viralgen VC in San Sebastian, Spain. Philippe also serves as the Chief Scientific Officer for AskBio Europe. His dual appointments allow the reinforcement of the US-Spanish strategic partnership.